Cerenome, Inc. (CNSY)
NASDAQ: CNSY · Real-Time Price · USD
2.755
-0.225 (-7.55%)
At close: Sep 4, 2026, 4:00 PM EDT
2.852
+0.097 (3.52%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Cerenome Employees
Cerenome had 28 employees as of December 31, 2025. The number of employees increased by 7 or 33.33% compared to the previous year.
Employees
28
Change (1Y)
7
Growth (1Y)
33.33%
Revenue / Employee
$150,107
Profits / Employee
-$931,714
Market Cap
20.91M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 28 | 7 | 33.33% |
| Dec 31, 2024 | 21 | 1 | 5.00% |
| Dec 31, 2023 | 20 | 3 | 17.65% |
| Dec 31, 2022 | 17 | 3 | 21.43% |
| Dec 31, 2021 | 14 | 2 | 16.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Longeveron | 38 |
| Lipocine | 14 |
| Cellectar Biosciences | 11 |
| Cocrystal Pharma | 10 |
| Neuphoria Therapeutics | 8 |
| Akari Therapeutics, | 6 |
| Marker Therapeutics | 5 |
| Pasithea Therapeutics | 5 |
CNSY News
- 16 days ago - Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines - GlobeNewsWire
- 21 days ago - Cerenome Reports Second Quarter 2026 Financial Results and Business Update - GlobeNewsWire
- 22 days ago - Cerenome Quarterly report: Q2 2026 - Filings
- 22 days ago - Cerenome Earnings release: Q2 2026 - Filings
- 23 days ago - Cerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding CNSide® Contracted Coverage to Over 150 Million Covered Lives - GlobeNewsWire
- 5 weeks ago - Cerenome Launches as an Integrated CNS Oncology Company - GlobeNewsWire
- 5 weeks ago - Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference - GlobeNewsWire
- 6 weeks ago - Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer - GlobeNewsWire